XIAO FANG ORD A (SHH) EQSW Exp:
Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics and traumatology, five senses, and disinfection. Shanghai Xiao Fang Pharmaceutical Co.,Ltd. was founded in 1993 and is based in Shanghai, China.
Market Cap & Net Worth: XIAO FANG ORD A (SHH) EQSW Exp: (603207)
XIAO FANG ORD A (SHH) EQSW Exp: (SHG:603207) has a market capitalization of $618.10 Million (CN¥4.54 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #15039 globally and #4015 in its home market, demonstrating a 0.61% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying XIAO FANG ORD A (SHH) EQSW Exp:'s stock price CN¥28.20 by its total outstanding shares 160820000 (160.82 Million).
XIAO FANG ORD A (SHH) EQSW Exp: Market Cap History: 2025 to 2026
XIAO FANG ORD A (SHH) EQSW Exp:'s market capitalization history from 2025 to 2026. Data shows growth from $627.30 Million to $618.10 Million (0.00% CAGR).
XIAO FANG ORD A (SHH) EQSW Exp: Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how XIAO FANG ORD A (SHH) EQSW Exp:'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 603207 by Market Capitalization
Companies near XIAO FANG ORD A (SHH) EQSW Exp: in the global market cap rankings as of March 18, 2026.
Key companies related to XIAO FANG ORD A (SHH) EQSW Exp: by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
XIAO FANG ORD A (SHH) EQSW Exp: Historical Marketcap From 2025 to 2026
Between 2025 and today, XIAO FANG ORD A (SHH) EQSW Exp:'s market cap moved from $627.30 Million to $ 618.10 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥618.10 Million | -1.47% |
| 2025 | CN¥627.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of XIAO FANG ORD A (SHH) EQSW Exp: was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $618.10 Million USD |
| MoneyControl | $618.10 Million USD |
| MarketWatch | $618.10 Million USD |
| marketcap.company | $618.10 Million USD |
| Reuters | $618.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.